Next, we studied the influx of mature myeloid and lymphoid cells to the periphery, more specifically at the tumor environment, by assessing the presence of total CD45+, CD11b+, and CD8+ cells after 21 and 35 days of tumor establishment (Figure 5E). The gene discussed is PTPRC; the disease is neoplasm.